[HTML][HTML] MR imaging of hepatocellular carcinoma: prospective intraindividual head-to-head comparison of the contrast agents gadoxetic acid and gadoteric acid
F Collettini, A Elkilany, MD Seta, IG Steffen… - Scientific Reports, 2022 - nature.com
The routine use of dynamic-contrast-enhanced MRI (DCE-MRI) of the liver using hepatocyte-
specific contrast agent (HSCA) as the standard of care for the study of focal liver lesions is …
specific contrast agent (HSCA) as the standard of care for the study of focal liver lesions is …
MR imaging of hepatocellular carcinoma: prospective intraindividual head-to-head comparison of the contrast agents gadoxetic acid and gadoteric acid.
F Collettini, A Elkilany, MD Seta, IG Steffen… - Scientific …, 2022 - search.ebscohost.com
The routine use of dynamic-contrast-enhanced MRI (DCE-MRI) of the liver using hepatocyte-
specific contrast agent (HSCA) as the standard of care for the study of focal liver lesions is …
specific contrast agent (HSCA) as the standard of care for the study of focal liver lesions is …
MR imaging of hepatocellular carcinoma: prospective intraindividual head-to-head comparison of the contrast agents gadoxetic acid and gadoteric acid
F Collettini, A Elkilany, MD Seta, IG Steffen… - Scientific …, 2022 - ui.adsabs.harvard.edu
The routine use of dynamic-contrast-enhanced MRI (DCE-MRI) of the liver using hepatocyte-
specific contrast agent (HSCA) as the standard of care for the study of focal liver lesions is …
specific contrast agent (HSCA) as the standard of care for the study of focal liver lesions is …
[HTML][HTML] MR imaging of hepatocellular carcinoma: prospective intraindividual head-to-head comparison of the contrast agents gadoxetic acid and gadoteric acid
F Collettini, A Elkilany, M Della Seta, IG Steffen… - Scientific …, 2022 - ncbi.nlm.nih.gov
The routine use of dynamic-contrast-enhanced MRI (DCE-MRI) of the liver using hepatocyte-
specific contrast agent (HSCA) as the standard of care for the study of focal liver lesions is …
specific contrast agent (HSCA) as the standard of care for the study of focal liver lesions is …
[PDF][PDF] MR imaging of hepatocellular carcinoma: prospective intraindividual head‑to‑head comparison of the contrast agents gadoxetic acid and gadoteric acid
JM Collettini, T Penzkofer, M Schmelzle… - Scientific …, 2022 - researchgate.net
Results The study included 23 patients (19 males and 4 females; mean age, 69 years;
range, 53–87 years) with HCC and underlying liver cirrhosis. The etiologies for liver cirrhosis …
range, 53–87 years) with HCC and underlying liver cirrhosis. The etiologies for liver cirrhosis …
MR imaging of hepatocellular carcinoma: prospective intraindividual head-to-head comparison of the contrast agents gadoxetic acid and gadoteric acid
F Collettini, A Elkilany, M Della Seta… - Scientific …, 2022 - pubmed.ncbi.nlm.nih.gov
The routine use of dynamic-contrast-enhanced MRI (DCE-MRI) of the liver using hepatocyte-
specific contrast agent (HSCA) as the standard of care for the study of focal liver lesions is …
specific contrast agent (HSCA) as the standard of care for the study of focal liver lesions is …
MR imaging of hepatocellular carcinoma: prospective intraindividual head-to-head comparison of the contrast agents gadoxetic acid and gadoteric acid.
F Collettini, A Elkilany, MD Seta, IG Steffen… - Scientific …, 2022 - europepmc.org
The routine use of dynamic-contrast-enhanced MRI (DCE-MRI) of the liver using hepatocyte-
specific contrast agent (HSCA) as the standard of care for the study of focal liver lesions is …
specific contrast agent (HSCA) as the standard of care for the study of focal liver lesions is …
MR imaging of hepatocellular carcinoma: prospective intraindividual head-to-head comparison of the contrast agents gadoxetic acid and gadoteric acid.
F Collettini, A Elkilany, MD Seta, IG Steffen… - Scientific …, 2022 - europepmc.org
The routine use of dynamic-contrast-enhanced MRI (DCE-MRI) of the liver using hepatocyte-
specific contrast agent (HSCA) as the standard of care for the study of focal liver lesions is …
specific contrast agent (HSCA) as the standard of care for the study of focal liver lesions is …